← Leaderboards
Gerard M Housey
Housey Pharmaceutical Research Lab
$4,296,517
Attributed
$4,296,517
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2006–15$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$4,296,517 · 5
By mechanism
R44$3,637,555 · 1
R43$658,962 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadSmall Business Innovation Research GrantBasePharmacologic SubstanceCellsExhibitsLaboratory ResearchDiabetes MellitusUnited States National Institutes Of HealthTechnologyMediatingScientistMarketingLicensingFoundationsSpecificityLaboratoriesPre-ClinicalScaffoldMolecularOralIn VivoBiological AvailabilityInsulin Signaling
Grant awards (9)
Novel Inhibitors of Multi-Drug-Resistant Mutants of BCR-ABL for the Treatment of Chronic Myelogenous Leukemia (CML) and Ph Positive Acute Lymphocytic Leukemia (ALL).$239,005
R43 · FY2015 · CA · contact PI
Isolation and Characterization of Low Molecular Weight Compounds Derived from Plant Extracts that Activate the IRS-2 Dependent Insulin Signaling Cascade.$170,341
R43 · FY2015 · DK · contact PI
"Discovery and Development of Anti-Diabetic Drugs."$880,003
R44 · FY2013 · DK · contact PI
"Discovery and Development of Anti-Diabetic Drugs."$975,307
R44 · FY2012 · DK · contact PI
"Discovery and Development of Anti-Diabetic Drugs."$1,018,907
R44 · FY2011 · DK · contact PI
Novel Inhibitors for the Treatment of Highly Drug-Resistant Chronic Myelogenous$149,616
R43 · FY2009 · CA · contact PI
Discovery and Development of Antidiabetic Drugs$287,027
R44 · FY2007 · DK · contact PI
Discovery and Development of Antidiabetic Drugs$476,311
R44 · FY2006 · DK · contact PI
Discovery and development of Antidiabetic Drugs$100,000
R43 · FY2003 · DK